Related Experiment Video
Updated: Aug 20, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
Is vaccine therapy the future in cancer prevention?
Abstract:
One vaccine designed to prevent cancer by preventing a precursor infection is already in common use, and at least one more is in the latter stages of clinical development. These vaccines are part of a new era of cancer immunoprophylaxis. Several further vaccines are in preclinical and clinical development, targeted at preventing cancer precursor infections, and these should add to our ability to prevent this common human disorder. However, vaccines to prevent cancers not triggered by infection are a more remote prospect, for a variety of reasons.
Insights
Cancer immunoprophylaxis is advancing with vaccines preventing precursor infections. While some are in use and development, vaccines for non-infectious cancers remain a distant goal.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- The development of cancer immunoprophylaxis represents a significant advancement in disease prevention.
- Vaccines targeting cancer-causing infections are a key focus in current research and clinical trials.
Discussion:
- Existing vaccines prevent cancers by targeting precursor infections, with more in development.
- The success of immunoprophylaxis for infectious-related cancers highlights its potential.
- Challenges remain in developing vaccines for cancers not linked to infections.
Key Insights:
- A new era of cancer immunoprophylaxis is emerging, driven by vaccines against precursor infections.
- Several vaccines are in various stages of development, aiming to prevent infection-related cancers.
- The efficacy of current and developing vaccines offers a promising strategy for cancer prevention.
Outlook:
- Further advancements in vaccine technology are expected to expand cancer prevention strategies.
- The development of vaccines for non-infectious cancers presents a long-term research objective.
- Continued research is crucial for broadening the scope of cancer immunoprophylaxis.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

